心肌存活性检测:STICH 之后何去何从,还是即将被 REVIVED 改写?
该综述批判性审视缺血性左心室功能不全患者心肌存活性检测的证据基础。传统模型认为大片功能障碍但存活心肌可从血运重建获益,但证据质量低。STICH 试验亚组分析显示存活心肌容量未能预测冠状动脉旁路移植术的疗效,作者探讨是否应放弃存活性检测或需新解读范式。
要点
- 传统模型假设大片存活心肌预测血运重建获益,但证据质量低。
- STICH 亚组分析显示存活心肌容量未预测 CABG 疗效。
- 需重新审视存活性检测在血运重建决策及更广泛领域的应用。
核心结论
- 传统存活性检测模型基于低质量证据,STICH 亚组分析挑战了存活心肌容量预测 CABG 疗效的观念。
研究设计与样本
- 本文为 state-of-the-art 综述,批判性审视存活性检测的证据基础,重点关注存活性、功能恢复、血运重建与预后之间假定交互作用。
主要发现
- STICH 随机试验亚组分析显示,存活心肌容量未能预测冠状动脉旁路移植术的有效性。
- 传统假设认为大片功能障碍但存活心肌患者从血运重建获益,无大片存活心肌者则不获益,该假设基于冬眠理论及低质量数据。
临床怎么用
- 采用教条式存活性检测方法可能导致患者被拒绝接受具有预后意义的重要治疗。
- 需探讨存活性检测是否应仅关联功能障碍心肌,并探索血运重建决策之外更广泛的用途。
局限性
- 传统存活性检测模型所依据的证据质量低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with ischaemic left ventricular dysfunction frequently undergo myocardial viability testing. The historical model presumes that those who have extensive areas of dysfunctional-yet-viable myocardium derive particular benefit from revascularization, whilst those without extensive viability do not. These suppositions rely on the theory of hibernation and are based on data of low quality: taking a dogmatic approach may therefore lead to patients being refused appropriate, prognostically important treatment. Recent data from a sub-study of the randomized STICH trial challenges these historical concepts, as the volume of viable myocardium failed to predict the effectiveness of coronary artery bypass grafting. Should the Heart Team now abandon viability testing, or are new paradigms needed in the way we interpret viability? This state-of-the-art review critically examines the evidence base for viability testing, focusing in particular on the presumed interactions between viability, functional recovery, revascularization and prognosis which underly the traditional model. We consider whether viability should relate solely to dysfunctional myocardium or be considered more broadly and explore wider uses of viability testingoutside of revascularization decision-making. Finally, we look forward to ongoing and future randomized trials, which will shape evidence-based clinical practice in the future.
引用
- Ryan M, Morgan H, Chiribiri A, et al. Myocardial viability testing: all STICHed up, or about to be REVIVED? Eur Heart J. 2022. PMID: 34791132. doi:10.1093/eurheartj/ehab729
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。